|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 14/59 | (2006.01) |
| C07K 14/755 | (2006.01) | ||
| C07K 14/79 | (2006.01) | ||
| A61K 38/00 | (2006.01) | ||
| A61K 35/14 | (2015.01) | ||
| A61K 38/37 | (2006.01) |
| (11) | Number of the document | 2822577 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13749382.1 |
| Date of filing the European patent application | 2013-02-15 | |
| (97) | Date of publication of the European application | 2015-01-14 |
| (45) | Date of publication and mention of the grant of the patent | 2019-02-06 |
| (46) | Date of publication of the claims translation | 2019-03-25 |
| (86) | Number | PCT/US2013/026521 |
| Date | 2013-02-15 |
| (87) | Number | WO 2013/123457 |
| Date | 2013-08-22 |
| (30) | Number | Date | Country code |
| 201261599305 P | 2012-02-15 | US | |
| 201261670553 P | 2012-07-11 | US | |
| 201361759785 P | 2013-02-01 | US |
| (72) |
KULMAN, John, US
|
| (73) |
Bioverativ Therapeutics Inc.,
225 Second Avenue, Waltham MA 02451,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Rekombinantiniai faktoriaus VIII baltymai |
| RECOMBINANT FACTOR VIII PROTEINS |
| Payment date | Validity (years) | Amount | |
| 2019-05-02 | 7 | 243.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2020-02-15 |